Latest News about Lykos Therapeutics
Recent news which mentions Lykos Therapeutics
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
From Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
From Benzinga
From Benzinga
From Benzinga
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
August 09, 2024
From Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.